MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
About this study
This project, mySmartSkin (MSS), includes an innovative Type 1 hybrid effectiveness-implementation trial designed to enhance the effects of MSS and simultaneously assess key implementation outcomes (e.g., cost, adoption) as well as contextual factors important for scale-up in community and health care settings where melanoma survivors receive follow-up care. A type 1 hybrid effectiveness-implementation design allows us to engage multilevel stakeholders throughout this process, evaluate the effectiveness of the enhanced MSS, and identify critical factors for wide-scale implementation. Aim 1 will focus on enhancing the previous version of MSS by collaborating with multi-level stakeholders in qualitative interviews and usability testing. Aim 2 will evaluate the effects of enhanced MSS on thorough skin-self examinations (SSE) in a randomized-control trial (RCT) and examine its impact on the diagnosis of new/recurrent melanomas. Aim 3 will focus on assessing selected implementation outcomes and identify factors relevant to future scale-up for widespread dissemination and implementation.
- Condition
- Melanoma
- Tested
- MySmartSkin enhancement, Educational webpage on Skin Self-Examination, Assess implementation outcomes
- Sponsor
- Rutgers, The State University of New Jersey
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 10
- Minimum age: 18 years
- Study condition: Melanoma
- Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma
- Three months to five years post-surgery
- No current evidence of cancer
- Not adherent to thorough SSE (i.e., did not check entire body at least once during the past three months)
- ≥ 18 years old
- Internet access
- Able to speak/read English
- Able to provide informed consent
Exclusion 1
- Children
Where
1 site, 1 recruiting
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Contact
-
Sharon Manne, PhD
732-235-6759 mannesl@cinj.rutgers.edu
-
Carolyn Heckman, PhD
732-266-9514 ch842@cinj.rutgers.edu
Potential match only. Final eligibility is determined by the study team.